Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders.

Valor LM, Viosca J, Lopez-Atalaya JP, Barco A.

Curr Pharm Des. 2013;19(28):5051-64. Review.

2.

CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement.

Lopez-Atalaya JP, Ciccarelli A, Viosca J, Valor LM, Jimenez-Minchan M, Canals S, Giustetto M, Barco A.

EMBO J. 2011 Aug 16;30(20):4287-98. doi: 10.1038/emboj.2011.299.

3.

Syndromic features and mild cognitive impairment in mice with genetic reduction on p300 activity: Differential contribution of p300 and CBP to Rubinstein-Taybi syndrome etiology.

Viosca J, Lopez-Atalaya JP, Olivares R, Eckner R, Barco A.

Neurobiol Dis. 2010 Jan;37(1):186-94. doi: 10.1016/j.nbd.2009.10.001. Epub 2009 Oct 12.

PMID:
19822209
4.

Chronic enhancement of CREB activity in the hippocampus interferes with the retrieval of spatial information.

Viosca J, Malleret G, Bourtchouladze R, Benito E, Vronskava S, Kandel ER, Barco A.

Learn Mem. 2009 Feb 23;16(3):198-209. doi: 10.1101/lm.1220309. Print 2009 Mar.

5.

Enhanced CREB-dependent gene expression increases the excitability of neurons in the basal amygdala and primes the consolidation of contextual and cued fear memory.

Viosca J, Lopez de Armentia M, Jancic D, Barco A.

Learn Mem. 2009 Feb 23;16(3):193-7. doi: 10.1101/lm.1254209. Print 2009 Mar.

PMID:
19237641
6.

Hunting for synaptic tagging and capture in memory formation.

Viosca J, Jancic D, López-Atalaya JP, Benito E.

J Neurosci. 2007 Nov 21;27(47):12761-3. Review. No abstract available.

Supplemental Content

Loading ...
Support Center